{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:33:59Z","timestamp":1762900439132,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100016209","name":"Bilimsel Ara\u015ft\u0131rma Projeleri, Erciyes \u00dcniversitesi","doi-asserted-by":"publisher","award":["TCD-2014-5098"],"award-info":[{"award-number":["TCD-2014-5098"]}],"id":[{"id":"10.13039\/501100016209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-023-02093-5","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T18:03:09Z","timestamp":1681408989000},"page":"2367-2377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unexpectedly high mutation rate of cyp11b1 compared to cyp21a2 in randomly-selected turkish women: a large screening study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1209-9602","authenticated-orcid":false,"given":"S.","family":"Polat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Karaburgu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Unluhizarci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Ozkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. K.","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Kelestimur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"2093_CR1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1056\/NEJMra021561","volume":"349","author":"PW Speiser","year":"2003","unstructured":"Speiser PW, White PC (2003) Congenital adrenal hyperplasia. N Engl J Med 349:776\u2013788. https:\/\/doi.org\/10.1056\/NEJMra021561","journal-title":"N Engl J Med"},{"key":"2093_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0889-8529(08)70016-1","volume":"30","author":"MI New","year":"2001","unstructured":"New MI (2001) Prenatal treatment of congenital adrenal hyperplasia: the United States experience. Endocrinol Metab Clin N Am 30:1\u201313","journal-title":"Endocrinol Metab Clin N Am"},{"key":"2093_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/er.2010-0013","volume":"32","author":"WL Miller","year":"2011","unstructured":"Miller WL, Auchus RJ (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 32:81\u2013151. https:\/\/doi.org\/10.1210\/er.2010-0013","journal-title":"Endocr Rev"},{"key":"2093_CR4","first-page":"451","volume":"3","author":"F Kelestimur","year":"2006","unstructured":"Kelestimur F (2006) Non-classic congenital adrenal hyperplasia. Pediatr Endocrinol Rev 3:451\u2013454","journal-title":"Pediatr Endocrinol Rev"},{"key":"2093_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1530\/EJE-13-0737","volume":"170","author":"S Polat","year":"2014","unstructured":"Polat S, Kulle A, Karaca Z, Akkurt I, Kurtoglu S, Kelestimur F, Gr\u00f6tzinger J, Holterhus PM, Riepe FG (2014) Characterisation of three novel CYP11B1 mutations in classic and non-classic 11beta-hydroxylase deficiency. Eur J Endocrinol 170:697\u2013706. https:\/\/doi.org\/10.1530\/EJE-13-0737","journal-title":"Eur J Endocrinol"},{"key":"2093_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/09513590903215466","volume":"26","author":"K Unluhizarci","year":"2010","unstructured":"Unluhizarci K, Kula M, Dundar M, Tanriverdi F, Israel S, Colak R, Dokmetas HS, Atmaca H, Bahceci M, Balci MK, Comlekci A, Bilen H, Akarsu E, Erem C, Kelestimur F (2010) The prevalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism. Gynecol Endocrinol 26:139\u2013143. https:\/\/doi.org\/10.3109\/09513590903215466","journal-title":"Gynecol Endocrinol"},{"key":"2093_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1046\/j.1365-2265.1996.8150825.x","volume":"45","author":"F Kele\u015ftimur","year":"1996","unstructured":"Kele\u015ftimur F, Sahin Y, Ayata D, Tutu\u015f A (1996) The prevalence of non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency among hirsute women in a Turkish population. Clin Endocrinol (Oxf) 45:381\u2013384. https:\/\/doi.org\/10.1046\/j.1365-2265.1996.8150825.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2093_CR8","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440\u20131447","journal-title":"J Clin Endocrinol Metab"},{"key":"2093_CR9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/jc.2003-031122","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR (2004) Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89:453\u2013462. https:\/\/doi.org\/10.1210\/jc.2003-031122","journal-title":"J Clin Endocrinol Metab"},{"key":"2093_CR10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1055\/s-2004-821307","volume":"112","author":"K Unluhizarci","year":"2004","unstructured":"Unluhizarci K, Gokce C, Atmaca H, Bayram F, Kelestimur F (2004) A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue. Exp Clin Endocrinol Diabetes 112:504\u2013509. https:\/\/doi.org\/10.1055\/s-2004-821307","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2093_CR11","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/S0026-0495(97)90077-9","volume":"46","author":"HF Escobar-Morreale","year":"1997","unstructured":"Escobar-Morreale HF, Serrano-Gotarredona J, Garc\u00eda-Robles R, Sancho J, Varela C (1997) Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist? Metabolism 46:902\u2013907","journal-title":"Metabolism"},{"key":"2093_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2337\/diacare.23.1.57","volume":"23","author":"E Bonora","year":"2000","unstructured":"Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57\u201363","journal-title":"Diabetes Care"},{"key":"2093_CR13","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1210\/jcem.77.6.7903314","volume":"77","author":"Y Naiki","year":"1993","unstructured":"Naiki Y, Kawamoto T, Mitsuuchi Y, Miyahara K, Toda K, Orii T, Imura H, Shizuta Y (1993) A nonsense mutation (TGG [Trp116]\u2013>TAG [Stop]) in CYP11B1 causes steroid 11 beta-hydroxylase deficiency. J Clin Endocrinol Metab 77:1677\u20131682. https:\/\/doi.org\/10.1210\/jcem.77.6.7903314","journal-title":"J Clin Endocrinol Metab"},{"key":"2093_CR14","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1210\/jcem.78.5.8175971","volume":"78","author":"A Wedell","year":"1994","unstructured":"Wedell A, Thil\u00e9n A, Ritz\u00e9n EM, Stengler B, Luthman H (1994) Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 78:1145\u20131152. https:\/\/doi.org\/10.1210\/jcem.78.5.8175971","journal-title":"J Clin Endocrinol Metab"},{"key":"2093_CR15","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1203\/00006450-199311000-00026","volume":"34","author":"YT Chang","year":"1993","unstructured":"Chang YT, Kappy MS, Iwamoto K, Wang J, Yang X, Pang S (1993) Mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene in a patient with classic salt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia. Pediatr Res 34:698\u2013700. https:\/\/doi.org\/10.1203\/00006450-199311000-00026","journal-title":"Pediatr Res"},{"key":"2093_CR16","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1210\/jc.2006-2163","volume":"92","author":"RS Ara\u00fajo","year":"2007","unstructured":"Ara\u00fajo RS, Mendonca BB, Barbosa AS, Lin CJ, Marcondes JA, Billerbeck AE, Bachega TA (2007) Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency. J Clin Endocrinol Metab 92:4028\u20134034. https:\/\/doi.org\/10.1210\/jc.2006-2163","journal-title":"J Clin Endocrinol Metab"},{"key":"2093_CR17","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1210\/jcem.83.9.5090","volume":"83","author":"ES Knochenhauer","year":"1998","unstructured":"Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078\u20133082. https:\/\/doi.org\/10.1210\/jcem.83.9.5090","journal-title":"J Clin Endocrinol Metab"},{"key":"2093_CR18","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","volume":"167","author":"E Carmina","year":"1992","unstructured":"Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA (1992) Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 167:1807\u20131812","journal-title":"Am J Obstet Gynecol"},{"key":"2093_CR19","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/00003081-199112000-00019","volume":"34","author":"RA Lobo","year":"1991","unstructured":"Lobo RA (1991) Hirsutism in polycystic ovary syndrome: current concepts. Clin Obstet Gynecol 34:817\u2013826","journal-title":"Clin Obstet Gynecol"},{"key":"2093_CR20","first-page":"840","volume":"85","author":"T Aono","year":"1977","unstructured":"Aono T, Miyazaki M, Miyake A, Kinugasa T, Kurachi K, Matsumoto K (1977) Responses of serum gonadotrophins to LH-releasing hormone and oestrogens in Japanese women with polycystic ovaries. Acta Endocrinol (Copenh) 85:840\u2013849","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2093_CR21","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1210\/jc.2004-1214","volume":"90","author":"D Glintborg","year":"2005","unstructured":"Glintborg D, Hermann AP, Brusgaard K, Hangaard J, Hagen C, Andersen M (2005) Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, Caucasian, hirsute patients compared with healthy controls. J Clin Endocrinol Metab 90:1347\u20131353. https:\/\/doi.org\/10.1210\/jc.2004-1214","journal-title":"J Clin Endocrinol Metab"},{"key":"2093_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1477-7827-9-144","volume":"9","author":"FR Tehrani","year":"2011","unstructured":"Tehrani FR, Rashidi H, Azizi F (2011) The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran lipid and glucose study. Reprod Biol Endocrinol 9:144. https:\/\/doi.org\/10.1186\/1477-7827-9-144","journal-title":"Reprod Biol Endocrinol"},{"key":"2093_CR23","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nrg2883","volume":"11","author":"RS Mani","year":"2010","unstructured":"Mani RS, Chinnaiyan AM (2010) Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences. Nat Rev Genet 11:819\u2013829. https:\/\/doi.org\/10.1038\/nrg2883","journal-title":"Nat Rev Genet"},{"key":"2093_CR24","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nrg2193","volume":"8","author":"JM Chen","year":"2007","unstructured":"Chen JM, Cooper DN, Chuzhanova N, F\u00e9rec C, Patrinos GP (2007) Gene conversion: mechanisms, evolution and human disease. Nat Rev Genet 8:762\u2013775. https:\/\/doi.org\/10.1038\/nrg2193","journal-title":"Nat Rev Genet"},{"key":"2093_CR25","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/j.1460-2075.1987.tb02414.x","volume":"6","author":"NR Rodrigues","year":"1987","unstructured":"Rodrigues NR, Dunham I, Yu CY, Carroll MC, Porter RR, Campbell RD (1987) Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia. EMBO J 6:1653\u20131661","journal-title":"EMBO J"},{"key":"2093_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1530\/EC-14-0032","volume":"3","author":"I Br\u00f8nstad","year":"2014","unstructured":"Br\u00f8nstad I, Breivik L, Methlie P, Wolff AS, Bratland E, Nermoen I, L\u00f8v\u00e5s K, Husebye ES (2014) Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia. Endocr Connect 3:67\u201374. https:\/\/doi.org\/10.1530\/EC-14-0032","journal-title":"Endocr Connect"},{"key":"2093_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/cen.12526","volume":"82","author":"M Barbaro","year":"2015","unstructured":"Barbaro M, Soardi FC, \u00d6stberg LJ, Persson B, de Mello MP, Wedell A, Lajic S (2015) In vitro functional studies of rare CYP21A2 mutations and establishment of an activity gradient for nonclassic mutations improve phenotype predictions in congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 82:37\u201344. https:\/\/doi.org\/10.1111\/cen.12526","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2093_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00439-002-0810-7","volume":"111","author":"PF Koppens","year":"2002","unstructured":"Koppens PF, Hoogenboezem T, Degenhart HJ (2002) Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes. Hum Genet 111:405\u2013410. https:\/\/doi.org\/10.1007\/s00439-002-0810-7","journal-title":"Hum Genet"},{"key":"2093_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/PDM.0b013e3181f24807","volume":"20","author":"M Kharrat","year":"2011","unstructured":"Kharrat M, Riahi A, Maazoul F, M\u2019Rad R, Chaabouni H (2011) Detection of a frequent duplicated CYP21A2 gene carrying a Q318X mutation in a general population with quantitative PCR methods. Diagn Mol Pathol 20:123\u2013127. https:\/\/doi.org\/10.1097\/PDM.0b013e3181f24807","journal-title":"Diagn Mol Pathol"},{"key":"2093_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/jp.2012.5","volume":"33","author":"O Lekarev","year":"2013","unstructured":"Lekarev O, Tafuri K, Lane AH, Zhu G, Nakamoto JM, Buller-Burckle AM, Wilson TA, New MI (2013) Erroneous prenatal diagnosis of congenital adrenal hyperplasia owing to a duplication of the CYP21A2 gene. J Perinatol 33:76\u201378. https:\/\/doi.org\/10.1038\/jp.2012.5","journal-title":"J Perinatol"},{"key":"2093_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2265.2008.03356.x","volume":"70","author":"HJ Zhang","year":"2009","unstructured":"Zhang HJ, Yang J, Zhang MN, Zhang W, Liu JM, Wang WQ, Ning G, Li XY (2009) Variations in the promoter of CYP21A2 gene identified in a Chinese patient with simple virilizing form of 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 70:201\u2013207. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03356.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2093_CR32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/jc.2004-1728","volume":"90","author":"SM Baumgartner-Parzer","year":"2005","unstructured":"Baumgartner-Parzer SM, Nowotny P, Heinze G, Waldh\u00e4usl W, Vierhapper H (2005) Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population. J Clin Endocrinol Metab 90:775\u2013778. https:\/\/doi.org\/10.1210\/jc.2004-1728","journal-title":"J Clin Endocrinol Metab"},{"key":"2093_CR33","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1210\/jcem.84.3.5550","volume":"84","author":"J Fitness","year":"1999","unstructured":"Fitness J, Dixit N, Webster D, Torresani T, Pergolizzi R, Speiser PW, Day DJ (1999) Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 84:960\u2013966. https:\/\/doi.org\/10.1210\/jcem.84.3.5550","journal-title":"J Clin Endocrinol Metab"},{"key":"2093_CR34","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2265.2006.02521.x","volume":"64","author":"O Admoni","year":"2006","unstructured":"Admoni O, Israel S, Lavi I, Gur M, Tenenbaum-Rakover Y (2006) Hyperandrogenism in carriers of CYP21 mutations: the role of genotype. Clin Endocrinol (Oxf) 64:645\u2013651. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02521.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2093_CR35","first-page":"650","volume":"37","author":"PW Speiser","year":"1985","unstructured":"Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI (1985) High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 37:650\u2013667","journal-title":"Am J Hum Genet"},{"key":"2093_CR36","first-page":"830","volume":"42","author":"SL Sherman","year":"1988","unstructured":"Sherman SL, Aston CE, Morton NE, Speiser PW, New MI (1988) A segregation and linkage study of classical and nonclassical 21-hydroxylase deficiency. Am J Hum Genet 42:830\u2013838","journal-title":"Am J Hum Genet"},{"key":"2093_CR37","first-page":"703","volume":"122","author":"M Dumi\u0107","year":"1990","unstructured":"Dumi\u0107 M, Brkljaci\u0107 L, Speiser PW, Wood E, Crawford C, Plavsi\u0107 V, Banicevi\u00e1c M, Radmanovi\u0107 S, Radica A, Kastelan A (1990) An update on the frequency of nonclassic deficiency of adrenal 21-hydroxylase in the Yugoslav population. Acta Endocrinol (Copenh) 122:703\u2013710","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2093_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.mce.2003.11.008","volume":"215","author":"M Lisurek","year":"2004","unstructured":"Lisurek M, Bernhardt R (2004) Modulation of aldosterone and cortisol synthesis on the molecular level. Mol Cell Endocrinol 215:149\u2013159. https:\/\/doi.org\/10.1016\/j.mce.2003.11.008","journal-title":"Mol Cell Endocrinol"},{"key":"2093_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.anngen.2003.09.001","volume":"47","author":"OM Alper","year":"2004","unstructured":"Alper OM, Erengin H, Manguo\u011flu AE, Bilgen T, Cetin Z, Dedeo\u011flu N, L\u00fcleci G (2004) Consanguineous marriages in the province of Antalya, Turkey. Ann Genet 47:129\u2013138. https:\/\/doi.org\/10.1016\/j.anngen.2003.09.001","journal-title":"Ann Genet"},{"key":"2093_CR40","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1530\/eje.0.1370670","volume":"137","author":"Y Sahin","year":"1997","unstructured":"Sahin Y, Kele\u015ftimur F (1997) The frequency of late-onset 21-hydroxylase and 11 beta-hydroxylase deficiency in women with polycystic ovary syndrome. Eur J Endocrinol 137:670\u2013674","journal-title":"Eur J Endocrinol"},{"key":"2093_CR41","doi-asserted-by":"publisher","first-page":"21321","DOI":"10.1074\/jbc.M501269200","volume":"280","author":"JL Thomas","year":"2005","unstructured":"Thomas JL, Boswell EL, Scaccia LA, Pletnev V, Umland TC (2005) Identification of key amino acids responsible for the substantially higher affinities of human type 1 3beta-hydroxysteroid dehydrogenase\/isomerase (3beta-HSD1) for substrates, coenzymes, and inhibitors relative to human 3beta-HSD2. J Biol Chem 280:21321\u201321328. https:\/\/doi.org\/10.1074\/jbc.M501269200","journal-title":"J Biol Chem"},{"key":"2093_CR42","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/cen.12394","volume":"80","author":"K Takasawa","year":"2014","unstructured":"Takasawa K, Ono M, Hijikata A, Matsubara Y, Katsumata N, Takagi M, Morio T, Ohara O, Kashimada K, Mizutani S (2014) Two novel HSD3B2 missense mutations with diverse residual enzymatic activities for Delta5-steroids. Clin Endocrinol (Oxf) 80:782\u2013789. https:\/\/doi.org\/10.1111\/cen.12394","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2093_CR43","doi-asserted-by":"publisher","first-page":"E191","DOI":"10.1210\/jc.2014-2676","volume":"100","author":"MS Baquedano","year":"2015","unstructured":"Baquedano MS, Ciaccio M, Marino R, Perez Garrido N, Ramirez P, Maceiras M, Turjanski A, Defelipe LA, Rivarola MA, Belgorosky A (2015) A novel missense mutation in the HSD3B2 gene, underlying nonsalt-wasting congenital adrenal hyperplasia. New insight into the structure-function relationships of 3beta-hydroxysteroid dehidrogenase type II. J Clin Endocrinol Metab 100:E191\u2013E196. https:\/\/doi.org\/10.1210\/jc.2014-2676","journal-title":"J Clin Endocrinol Metab"},{"key":"2093_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1046\/j.1365-2265.2000.00873.x","volume":"52","author":"S Marui","year":"2000","unstructured":"Marui S, Castro M, Latronico AC, Elias LL, Arnhold IJ, Moreira AC, Mendonca BB (2000) Mutations in the type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls. Clin Endocrinol (Oxf) 52:67\u201375","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2093_CR45","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1210\/jcem.85.5.6581","volume":"85","author":"N Alos","year":"2000","unstructured":"Alos N, Moisan AM, Ward L, Desrochers M, Legault L, Leboeuf G, Van Vliet G, Simard J (2000) A novel A10E homozygous mutation in the HSD3B2 gene causing severe salt-wasting 3beta-hydroxysteroid dehydrogenase deficiency in 46, XX and 46, XY French-Canadians: evaluation of gonadal function after puberty. J Clin Endocrinol Metab 85:1968\u20131974. https:\/\/doi.org\/10.1210\/jcem.85.5.6581","journal-title":"J Clin Endocrinol Metab"},{"key":"2093_CR46","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1172\/JCI104666","volume":"41","author":"AM Bongiovanni","year":"1962","unstructured":"Bongiovanni AM (1962) The adrenogenital syndrome with deficiency of 3 beta-hydroxysteroid dehydrogenase. J Clin Investig 41:2086\u20132092. https:\/\/doi.org\/10.1172\/JCI104666","journal-title":"J Clin Investig"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02093-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02093-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02093-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T01:09:53Z","timestamp":1696640993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02093-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["2093"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02093-5","relation":{},"ISSN":["1720-8386"],"issn-type":[{"type":"electronic","value":"1720-8386"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"25 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest relevant to the subject matter or materials included in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of Medical School at Erciyes University.\u00a0All procedures performed in studies involving human participants and\/or animals were in accordance with the\u00a0ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and\u00a0its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}